{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:07:51Z","timestamp":1760188071050},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"vor","delay-in-days":6428,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[2002]]},"DOI":"10.1254\/jjp.89.255","type":"journal-article","created":{"date-parts":[[2002,8,26]],"date-time":"2002-08-26T16:44:18Z","timestamp":1030380258000},"page":"255-266","source":"Crossref","is-referenced-by-count":26,"title":["Curative Effect of Combined Treatment With Alendronate and 1 \u03b1-Hydroxyvitamin D3 on Bone Loss by Ovariectomy in Aged Rats"],"prefix":"10.1016","volume":"89","author":[{"given":"Masaya","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Komoriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.89.255_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00006254-199908000-00024","article-title":"Postmenopausal osteoporosis","volume":"54","author":"Watts","year":"1999","journal-title":"Obstet Gynecol Surv"},{"key":"10.1254\/jjp.89.255_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.med.46.1.249","article-title":"Treatment of osteoporosis","volume":"46","author":"Prestwood","year":"1995","journal-title":"Annu Rev Med"},{"key":"10.1254\/jjp.89.255_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/8756-3282(94)00035-X","article-title":"Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models [erratum 17, 333 (1995)]","volume":"16","author":"Azuma","year":"1995","journal-title":"Bone"},{"key":"10.1254\/jjp.89.255_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.96.1.133","article-title":"Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro","volume":"96","author":"Fisher","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.89.255_bib5","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action. Alendr-onate localization in rat bone and effects on osteoclast ultrastructure","volume":"88","author":"Sato","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1254\/jjp.89.255_bib6","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U","article-title":"Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group","volume":"42","author":"Hochberg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1254\/jjp.89.255_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01623652","article-title":"Rationale for the use of alendronate in osteoporosis","volume":"5","author":"Kanis","year":"1995","journal-title":"Osteoporos Int"},{"key":"10.1254\/jjp.89.255_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1507\/endocrj.45.191","article-title":"A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. The Alendronate Research Group","volume":"45","author":"Shiraki","year":"1998","journal-title":"Endocr J"},{"key":"10.1254\/jjp.89.255_bib9","first-page":"894","article-title":"Diphosphonates in Paget\u2019s disease","volume":"1","author":"Russell","year":"1974","journal-title":"Lancet"},{"key":"10.1254\/jjp.89.255_bib10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2165\/00003495-199142060-00003","article-title":"Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease","volume":"42","author":"Fleisch","year":"1991","journal-title":"Drugs"},{"key":"10.1254\/jjp.89.255_bib11","first-page":"128","article-title":"Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats","volume":"286","author":"Azuma","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.89.255_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jbmr.5650060405","article-title":"The bisphospho-nate alendronate (MK-217) inhibits bone loss due to ovariec-tomy in rats","volume":"6","author":"Seedor","year":"1991","journal-title":"J Bone Miner Res"},{"key":"10.1254\/jjp.89.255_bib13","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/jbmr.5650071207","article-title":"Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats","volume":"7","author":"Toolan","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1254\/jjp.89.255_bib14","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1359\/jbmr.1998.13.11.1721","article-title":"Human osteoclast formation and activity in vitro: effects of alendronate","volume":"13","author":"Breuil","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1254\/jjp.89.255_bib15","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.93.7.3068","article-title":"Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate","volume":"93","author":"Schmidt","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.89.255_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S8756-3282(97)00006-9","article-title":"Effect of alendr-onate treatment on the osteoclastogenic potential of bone marrow cells in mice","volume":"20","author":"van Beek","year":"1997","journal-title":"Bone"},{"key":"10.1254\/jjp.89.255_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jbmr.5650050107","article-title":"Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy","volume":"5","author":"Sato","year":"1990","journal-title":"J Bone Miner Res"},{"key":"10.1254\/jjp.89.255_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"10.1254\/jjp.89.255_bib19","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1007\/BF03194363","article-title":"Vitamin D for the treatment of osteoporosis","volume":"7","author":"Nakamura","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1254\/jjp.89.255_bib20","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1007\/BF03194338","article-title":"1,25-Dihydroxyvitamin D3 in the pathogenesis and treatment of osteoporosis","volume":"7","author":"DeLuca","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1254\/jjp.89.255_bib21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-113-9-649","article-title":"Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study","volume":"113","author":"Gallagher","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1254\/jjp.89.255_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","article-title":"Treatment of postmenopausal osteoporosis with calcitriol or calcium","volume":"326","author":"Tilyard","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1254\/jjp.89.255_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/8756-3282(95)80023-J","article-title":"Mouse primary osteoblasts express vitamin D3 25-hydroxylase mRNA and convert 1 \u03b1-hydroxyvitamin D3 into 1a ,25-dihydroxyvitamin D3","volume":"16","author":"Ichikawa","year":"1995","journal-title":"Bone"},{"key":"10.1254\/jjp.89.255_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF01621903","article-title":"The development of vitamin D3 analogues for the treatment of osteoporosis","volume":"3","author":"Nishii","year":"1993","journal-title":"Osteoporos Int"},{"key":"10.1254\/jjp.89.255_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s002239900197","article-title":"Is there a differential response to alfacalcidol and vitamin D in the treatment of osteoporosis?","volume":"60","author":"Francis","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"10.1254\/jjp.89.255_bib26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3181\/00379727-199-43371C","article-title":"Vitamin D in the treatment of osteoporosis","volume":"199","author":"Fujita","year":"1992","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1254\/jjp.89.255_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00003086-199403000-00033","article-title":"Alfacalcidol (alphaD3) and calcium in osteoporosis","volume":"300","author":"Menczel","year":"1994","journal-title":"Clin Orthop"},{"key":"10.1254\/jjp.89.255_bib28","first-page":"47","article-title":"Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1a(OH)-vitamin D3","volume":"3","author":"Orimo","year":"1987","journal-title":"Bone Miner"},{"key":"10.1254\/jjp.89.255_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00305521","article-title":"Effects of 1a-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis","volume":"54","author":"Orimo","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"10.1254\/jjp.89.255_bib30","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1210\/endo.137.4.8625911","article-title":"Effect of 1 \u03b1-vitamin D3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat model","volume":"137","author":"Aerssens","year":"1996","journal-title":"Endocrinology"},{"key":"10.1254\/jjp.89.255_bib31","first-page":"173","article-title":"Comparison of therapeutic usefulness of vitamin D3 analogs on osteoporosis caused by ovariectomy in rats","volume":"7","author":"Izawa","year":"1985","journal-title":"Acta Vitaminol Enzymol"},{"key":"10.1254\/jjp.89.255_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1359\/jbmr.2000.15.4.770","article-title":"Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen","volume":"15","author":"Shiraishi","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1254\/jjp.89.255_bib33","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1073\/pnas.79.10.3325","article-title":"1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with post-menopausal osteoporosis","volume":"79","author":"Gallagher","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.89.255_bib34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S8756-3282(00)00386-0","article-title":"Additive effects of combined treatment with etidronate and alfacalcidol on bone mass and mechanical properties in ovariectomized rats","volume":"27","author":"Nishikawa","year":"2000","journal-title":"Bone"},{"key":"10.1254\/jjp.89.255_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1210\/endo-124-1-7","article-title":"The aged rat model of ovarian hormone deficiency bone loss","volume":"124","author":"Kalu","year":"1989","journal-title":"Endocrinology"},{"key":"10.1254\/jjp.89.255_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","article-title":"The ovariectomized rat model of postmenopausal bone loss","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner"},{"key":"10.1254\/jjp.89.255_bib37","series-title":"Bisphospho-nates in Bone Disease Fourth Edition","first-page":"34","article-title":"Actions: Bisphosphonates-preclinical","author":"Fleisch","year":"2000"},{"key":"10.1254\/jjp.89.255_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"10.1254\/jjp.89.255_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s002239900124","article-title":"Measurement of intact rat osteocalcin in osteoblast (ROS17\/2.8) cells and in ovariectomized rats with a sandwich enzyme immunoassay","volume":"59","author":"Ohta","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1254\/jjp.89.255_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0003-2697(88)90274-6","article-title":"Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography","volume":"169","author":"Black","year":"1988","journal-title":"Anal Biochem"},{"key":"10.1254\/jjp.89.255_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jbmr.5650070310","article-title":"Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometry","volume":"7","author":"Ammann","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1254\/jjp.89.255_bib42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF02556693","article-title":"Compressive strength, ash weight, and volume of vertebral trabecular bone in experimental fluorosis in pigs","volume":"40","author":"Mosekilde","year":"1987","journal-title":"Calcif Tissue Int"},{"key":"10.1254\/jjp.89.255_bib43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1210\/endo-129-1-421","article-title":"The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1 - 34) and hPTH-(1 - 84)","volume":"129","author":"Mosekilde","year":"1991","journal-title":"Endocrinology"},{"key":"10.1254\/jjp.89.255_bib44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00003086-198601000-00040","article-title":"Biomechanical effects of intramedullary reaming and nailing on intact femora in rats","volume":"202","author":"Molster","year":"1986","journal-title":"Clin Orthop"},{"key":"10.1254\/jjp.89.255_bib45","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/jbmr.5650100613","article-title":"Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats","volume":"10","author":"Katsumata","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1254\/jjp.89.255_bib46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1359\/jbmr.2001.16.4.671","article-title":"Low-intensity pulsed ultrasound accelerates rat femoral fracture healing by acting on the various cellular reactions in the fracture callus","volume":"16","author":"Azuma","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1254\/jjp.89.255_bib47","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF02555748","article-title":"Quantitative mor-phometric evaluation of the inhibitory activity of new amino-bisphosphonates on bone resorption in the rat","volume":"38","author":"Schenk","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"10.1254\/jjp.89.255_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1254\/jjp.80.67","article-title":"Inhibitory effect of vitamin K2 (menatetrenone) on bone resorption in ovariectomized rats: a histomorphometric and dual energy X-ray absorptiometric study","volume":"80","author":"Akiyama","year":"1999","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.89.255_bib49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"10.1254\/jjp.89.255_bib50","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0960-894X(00)80125-0","article-title":"Effects of 1,25(OH)2D3 and vitamin D analogues on developmental control of cell growth and tissue-specific expression during osteoblast differentiation","volume":"3","author":"Stein","year":"1993","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1254\/jjp.89.255_bib51","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jbmr.5650080713","article-title":"Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats","volume":"8","author":"Lauritzen","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.1254\/jjp.89.255_bib52","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/8756-3282(95)00113-R","article-title":"The anabolic effect of human PTH (1 - 34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate \u2014 is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?","volume":"16","author":"Delmas","year":"1995","journal-title":"Bone"},{"key":"10.1254\/jjp.89.255_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/8756-3282(95)00436-X","article-title":"Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis","volume":"18","author":"Devogelaer","year":"1996","journal-title":"Bone"},{"key":"10.1254\/jjp.89.255_bib54","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1254\/jjp.89.255_bib55","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1172\/JCI116872","article-title":"The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates","volume":"92","author":"Balena","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1254\/jjp.89.255_bib56","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jbmr.5650070812","article-title":"The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons","volume":"7","author":"Thompson","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1254\/jjp.89.255_bib57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00044011-199815030-00008","article-title":"Effects of combined treatment with calcitriol plus alendronate on bone turnover in postmenopausal osteoporosis two years of continuous treatment","volume":"15","author":"Frediani","year":"1998","journal-title":"Clin Drug Invest"},{"key":"10.1254\/jjp.89.255_bib58","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/ard.57.6.346","article-title":"Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women","volume":"57","author":"Masud","year":"1998","journal-title":"Ann Rheum Dis"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819301106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819301106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T09:04:30Z","timestamp":1682327070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819301106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002]]}},"alternative-id":["S0021519819301106"],"URL":"https:\/\/doi.org\/10.1254\/jjp.89.255","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}